- A New Frontier for Convergence in Gastroenterology and Hepatology
Nov. 28(Thu) 09:00-10:30 |
Noticeable research of liver disease in year 2019 | Convention Hall A+B (4F) |
Chair(s) | Jung-Hwan Yoon (Korea), Kwan Soo Byun (Korea) | |
09:00-09:22 | Viral hepatitis | Hyung Joon Yim (Korea) |
09:22-09:44 | Alcohol-related and non-alcoholic fatty liver diseases | Yong Kyun Cho (Korea) |
09:44-10:06 | Liver cirrhosis and complications | Moon Young Kim (Korea) |
10:06-10:28 | Hepatocellular carcinoma | Ju Hyun Shim (Korea) |
Nov. 28(Thu) 11:00-12:30 |
Updates in GERD | Emerald Hall B (3F) |
Chair(s) | Sung Pyo Hong (Korea), Suck Chei Choi (Korea) | |
11:00-11:22 | Novel new options in the medical management of GERD | Nayoung Kim (Korea) |
11:22-11:44 | Usefulness of esophageal impedance measurement in diagnosis of GERD | Daniel Sifrim (UK) |
11:44-12:06 | The Lyon Consensus; how is it differ from previous ones? | Edoardo Savarino (Italy) |
12:06-12:28 | Current status of endoscopic management in GERD | Yuto Shimamura (Japan) |
Nov. 28(Thu) 14:00-15:30 |
Modulation of gut-liver axis in liver diseases: How far have we come? | Convention Hall A+B (4F) |
Chair(s) | Jin Mo Yang (Korea), Kwang Cheol Koh (Korea) | |
14:00-14:20 | Serotonin signals through a gut-liver axis to regulate hepatic steatosis | Hail Kim (Korea) |
14:20-14:40 | Dysbiosis in patients with liver cirrhosis | Do Seon Song (Korea) |
14:40-15:00 | Gut microbiome and hepatocarcinogenesis | Su Jong Yu (Korea) |
15:00-15:20 | Modulation of gut-liver axis in liver diseases: How far have we come? | Ki Tae Suk (Korea) |
15:20-15:30 | Discussion |
Nov. 28(Thu) 16:00-17:30 |
Recent updates in management of liver diseases | Convention Hall A+B (4F) |
Chair(s) | Kwang-Hyub Han (Korea), Han Chu Lee (Korea) | |
16:00-16:20 | Clinical development of new HBV therapies | Sang Hoon Ahn (Korea) |
16:20-16:40 | Management of diabetes and dyslipidemia in patients with nonalcoholic steatohepatitis | Seung-Hyun Ko (Korea) |
16:40-17:00 | Autoimmune hepatitis in real practice | Kang Mo Kim (Korea) |
17:00-17:20 | Local ablation therapy of hepatocellular carcinoma | Seung Kak Shin (Korea) |
17:20-17:30 | Discussion |
Nov. 29(Fri) 09:00-10:30 |
Limits and prospects of acid inhibitors | Convention Hall A (4F) |
Chair(s) | Yong Chan Lee (Korea), Shin Maeda (Japan) | |
09:00-09:22 | Current long-term use of PPI in Asia | Kee Don Choi (Korea) |
09:22-09:44 | PPI and GI tumor: Really associated? | Wai Keung Leung (Hong Kong) |
09:44-10:06 | Is P-CAB really superior to PPI in H. pylori eradication? | Shin Maeda (Japan) |
10:06-10:28 | GERD treatment: which is your choice between PPIs and P-CABs? | Beom Jin Kim (Korea) |
Nov. 29(Fri) 09:00-10:30 |
Optimal strategies of colonoscopy in LGI disease | Convention Hall B (4F) |
Chair(s) | Suk-Kyun Yang (Korea), Sung-Ae Jung (Korea) | |
09:00-09:22 | Endoscopic findings mimicking inflammatory bowel disease | Jaeyoung Chun (Korea) |
09:22-09:44 | How to conduct surveillance of dysplasia in IBD | Soo-Kyung Park (Korea) |
09:44-10:06 | Measures for the high quality colonoscopy | Hoon Sup Koo (Korea) |
10:06-10:28 | Polypectomy strategies base on polyp size and characteristics | Yunho Jung (Korea) |
Nov. 29(Fri) 09:00-10:30 |
Prevention and treatment of cancer-related infection: tip for clinical practice | Diamond Hall (3F) |
Chair(s) | Hyunyong Jeong (Korea), Ji Kon Ryu (Korea) | |
09:00-09:18 | Vaccination for cancer patients; When and What? | Kang Il Jun (Korea) |
09:18-09:36 | Role of myeloid growth factor during chemotherapy | Su Jin Kim (Korea) |
09:36-09:54 | Evaluation and management of cancer-related fever | Hee Seung Lee (Korea) |
09:54-10:12 | Prevention of reactivation of tuberculosis | Chul Ho Oak (Korea) |
10:12-10:30 | Screening and prevention of hepatitis B, C during chemotherapy | Sae Hwan Lee (Korea) |
Nov. 29(Fri) 11:00-12:30 |
Recent updates of esophageal motility disorder | Convention Hall C (4F) |
Chair(s) | Kwang Jae Lee (Korea), Moo-In Park (Korea) | |
11:00-11:22 | Classification | Kee Wook Jung (Korea) |
11:22-11:44 | Diagnostic approach | Yu Kyung Cho (Korea) |
11:44-12:06 | Phamacologic therapheutic apporach | Yang Won Min (Korea) |
12:06-12:28 | Interventional therapheutic approach | Su Jin Hong (Korea) |
Nov. 29(Fri) 11:00-12:30 |
Recent advances in colorectal cancer screening | Diamond Hall (3F) |
Chair(s) | Dong Kyung Chang (Korea), Joseph J. Y. Sung (Hong Kong) | |
11:00-11:22 | Long-term outcome of FIT-based colorectal cancer screening program | Han-Mo Chiu (Taiwan) |
11:22-11:44 | Recent advances in colorectal cancer screening | Jae Myung Cha (Korea) |
11:44-12:06 | Increasing trend in young- onset colorectal cancer in Asia | Joseph J. Y. Sung (Hong Kong) |
12:06-12:28 | Surveillance recommendations for hereditary colorectal cancer syndrome | Bo-In Lee (Korea) |
Nov. 29(Fri) 14:00-15:30 |
Gut microbiota and diet in IBS | Convention Hall C (4F) |
Chair(s) | Myung-Gyu Choi (Korea), Kyu Chan Huh (Korea) | |
14:00-14:22 | Gut microbiota in the pathophysiology of IBS | Chang Hwan Choi (Korea) |
14:22-14:44 | Interactions between diet and gut microbiota | Kyung Ho Song (Korea) |
14:44-15:06 | Diet therapies for IBS | Seong-Eun Kim (Korea) |
15:06-15:28 | Microbiota-based therapies for IBS | Young-Seok Cho (Korea) |
Nov. 29(Fri) 14:00-15:30 |
Colorectal cancer: New topic and issue | Emerald Hall B (3F) |
Chair(s) | Seunja Park (Korea), Yoon Tae Jeen (Korea) | |
14:00-14:22 | The current understanding and optimal approach of early-onset colorectal cancer | Jong Pil Im (Korea) |
14:22-14:44 | Carbon-ion therapy for recurrent rectal cancer | Jee Suk Chang (Korea) |
14:44-15:06 | Emerging treatment in recurrent and metastatic colorectal cancer | Seong Hoon Shin (Korea) |
15:06-15:28 | Future clinical and translational research in colorectal cancer | Bun Kim (Korea) |
Nov. 30(Sat) 16:00-17:30 |
Treating acute pancreatitis; what's next? | Convention Hall A (4F) |
Chair(s) | Yong-Tae Kim (Korea), Young Deok Cho (Korea) | |
16:00-16:22 | Etiology and diagnosis, severity classification | Jun Kyu Lee (Korea) |
16:22-16:44 | Optimal medical management | Rungsun Rerknimitr (Thailand) |
16:44-17:06 | Optimal Endoscopic management | Ji Young Bang (USA) |
17:06-17:28 | Surveillence | Se Woo Park (Korea) |